Camrelizumab Plus Apatinib in Advanced Cervical Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
J. Clin. Oncol 2020 Oct 14;[EPub Ahead of Print], C Lan, J Shen, Y Wang, J Li, Z Liu, M He, X Cao, J Ling, J Huang, M Zheng, G Zou, H Yan, Q Liu, F Yang, W Wei, Y Deng, Y Xiong, X HuangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.